ID   CAA48823; SV 1; linear; mRNA; STD; HUM; 441 BP.
XX
PA   X69079.1
XX
DT   17-MAR-1993 (Rel. 35, Created)
DT   07-OCT-2008 (Rel. 97, Last updated, Version 44)
XX
DE   Homo sapiens (human) hypothetical protein
XX
KW   .
XX
OS   Homo sapiens (human)
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
XX
RN   [1]
RA   Minty A.J.;
RT   ;
RL   Submitted (02-NOV-1992) to the INSDC.
RL   A.J. Minty, Sanofi-Elf Bio Recherches, Labege Innopole, Voie 1, BP 137,
RL   31676 Labege Cedex, FRANCE
XX
RN   [2]
RX   DOI; 10.1038/362248a0.
RX   PUBMED; 8096327.
RA   Minty A.J., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M.,
RA   Labit C., Leplatois P., Liauzun P., Miloux B., Minty C., Casellas P.,
RA   Loison G., Lupker J., Shire D., Ferrara P., Caput D.;
RT   "Interleukin-13 is a new human lymphokine regulating inflammatory and
RT   immune responses";
RL   Nature 362(6417):248-250(1993).
XX
DR   MD5; ad341ca70e2779383e965040c1d2d12f.
XX
FH   Key             Location/Qualifiers
FH
FT   source          1..441
FT                   /organism="Homo sapiens"
FT                   /chromosome="5q 23-31"
FT                   /mol_type="mRNA"
FT                   /cell_type="peripheral blood lymphocytes"
FT                   /db_xref="taxon:9606"
FT   CDS             X69079.1:15..455
FT                   /gene="NC30"
FT                   /note="alternative"
FT                   /note="ATG at 15 is an alternative start codon"
FT                   /db_xref="GOA:P35225"
FT                   /db_xref="H-InvDB:HIT000322955.14"
FT                   /db_xref="HGNC:HGNC:5973"
FT                   /db_xref="InterPro:IPR001325"
FT                   /db_xref="InterPro:IPR009079"
FT                   /db_xref="InterPro:IPR018096"
FT                   /db_xref="InterPro:IPR020470"
FT                   /db_xref="PDB:1GA3"
FT                   /db_xref="PDB:1IJZ"
FT                   /db_xref="PDB:1IK0"
FT                   /db_xref="PDB:1J9U"
FT                   /db_xref="PDB:3BPO"
FT                   /db_xref="PDB:3G6D"
FT                   /db_xref="PDB:3ITR"
FT                   /db_xref="PDB:3ITS"
FT                   /db_xref="PDB:3L5W"
FT                   /db_xref="PDB:3L5X"
FT                   /db_xref="PDB:3LB6"
FT                   /db_xref="PDB:4I77"
FT                   /db_xref="PDB:4PS4"
FT                   /db_xref="PDB:5E4E"
FT                   /db_xref="PDB:5L6Y"
FT                   /db_xref="UniProtKB/Swiss-Prot:P35225"
FT                   /experiment="experimental evidence, no additional details
FT                   recorded"
FT                   /protein_id="CAA48823.1"
FT                   /translation="MHPLLNPLLLALGLMALLLTTVIALTCLGGFASPGPVPPSTALRE
FT                   LIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAALESLINVSGCSAIEKTQRMLSGFC
FT                   PHKVSAGQFSSLHVRDTKIEVAQFVKDLLLHLKKLFREGRFN"
XX
SQ   Sequence 441 BP; 92 A; 132 C; 113 G; 104 T; 0 other;
     atgcatccgc tcctcaatcc tctcctgttg gcactgggcc tcatggcgct tttgttgacc        60
     acggtcattg ctctcacttg ccttggcggc tttgcctccc caggccctgt gcctccctct       120
     acagccctca gggagctcat tgaggagctg gtcaacatca cccagaacca gaaggctccg       180
     ctctgcaatg gcagcatggt atggagcatc aacctgacag ctggcatgta ctgtgcagcc       240
     ctggaatccc tgatcaacgt gtcaggctgc agtgccatcg agaagaccca gaggatgctg       300
     agcggattct gcccgcacaa ggtctcagct gggcagtttt ccagcttgca tgtccgagac       360
     accaaaatcg aggtggccca gtttgtaaag gacctgctct tacatttaaa gaaacttttt       420
     cgcgagggac ggttcaactg a                                                 441
//